4576 D.WESTERN THERAPEUTICS INST
- 91
- 00.00%
D.WESTERN THERAPEUTICS INST News
Emerging Market Outlook: Amid severe year-to-date low updates, will the first IPO in a long time lead to an improvement in investor sentiment
■The reason for the rebound was missed and year-to-date lows were updated day by day. Emerging markets continued to fall this week. As for the gain/fall rate for the same period, the weakness of emerging markets was conspicuous, with the Nikkei Average being -0.36%, while the growth market index was -3.17% and the growth market 250 index was -3.92%. Financial results announcements for emerging markets also went round, and securities company reports gradually began to come out, so there was a possibility that review movements would intensify, but the main forces such as the Growth Market Core Index constituent stocks remained weak in general. Groß
Emerging Market Stock Digest: DWTI's Year-Old Low, Eyes Stop-High
＜4576＞ DWTI 103-8 has been low since the beginning. It has been announced that the 1st unsecured ordinary corporate bonds (private placement bonds) and 130,000 stock acquisition rights will be issued. The ratio of the number of potential shares (13 million shares) to the total number of issued shares is 40.46%, and sales are dominant due to concerns about future dilution. The raised funds of 1,427 billion yen will be used for corporate bond reimbursement funds and development funds for the glaucoma treatment agent “H-1337.” Redeem the remaining 1st unsecured convertible corporate bond type corporate bond with stock acquisition rights,
DWTI - year-to-date low, issuance of unsecured corporate bonds and stock acquisition rights, 1.4 billion yen of raised funds used for reimbursement and development funds
Year-to-date low. It has been announced that the 1st unsecured ordinary corporate bonds (private placement bonds) and 130,000 stock acquisition rights will be issued. The ratio of the number of potential shares (13 million shares) to the total number of issued shares is 40.46%, and sales are dominant due to concerns about future dilution. The raised funds of 1,427 billion yen will be used for corporate bond reimbursement funds and development funds for the glaucoma treatment agent “H-1337.” Redeem the remaining 1st unsecured convertible corporate bond type corporate bond with stock acquisition rights, and obtain the 11th stock acquisition rights that also remain
Volume change rate ranking (10:00) ~ Kyoritsu information, IC, etc. are ranked
* In the volume change rate ranking, it is possible to know the interest of market participants, such as shopping trends, by comparing the average turnover for the last 5 days with the turnover on the day of distribution. ■Top Volume Change Rate [5/20 at 10:32] (as of 5/20 10:32) Stock Code Stock Name Volume 5 Day Average Volume Volume Change Rate Stock Price Change Rate ＜1308＞ Listed TPX 4572846 634570.572 331.93% 0.
Samantha JP, DWTI, etc.
＜3461＞Sell Parma Real Estate for Sale (self-storage facility in Setagaya-ku, Tokyo) ＜3479＞sign a capital and business alliance agreement with TKP Lilicala ＜9827＞ ＜4055＞establish a T&S subsidiary ＜4576＞Acquire and cancel all remaining stock acquisition rights in DWTI 1st Unsecured Convertible Bonds Type New Stock Acquisition Rights Reimbursement 12th Issue of Stock Acquisition Rights (13 million potential shares, approximately 1,436 billion yen raised) ＜7829＞Samantha Profit from sale of JP fixed assets 4.
D.WESTERN THERAPEUTICS INST: Confirmation
D.WESTERN THERAPEUTICS INST: Quarterly Report - 27th Quarter 1st Quarter (2024/01/01 - 2024/03/31)
D.WESTERN THERAPEUTICS INST: Summary of Financial Results for the 1st Quarter of the Fiscal Year Ending 2024/12 [Japanese GAAP] (Consolidated)
Taiseiken, Obayashi Corporation, Toray, Shiono Yoshi (13th) (1417-5070)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/13 (Mon) ＜1417＞Miraite One ＜1435＞Robohome＜146A＞Colombia ＜1515＞Nippon Steel Mining ＜1518＞Mitsui Matsushima HD ＜1663＞K&O Energy＜167A＞Ryosan Ryoyo ＜1736＞Autech ＜174
Volume change rate ranking (9:00) ~ Niitaka, Showa HD, etc. are ranked
* In the volume change rate ranking, it is possible to know the interest of market participants, such as shopping trends, by comparing the average turnover for the last 5 days with the turnover on the day of distribution. ■Top Volume Change Rate [as of 3/28 9:33] (Last 5 Day Average Volume Comparison) Stock Code Stock Name Volume 5 Day Average Volume Volume Change Rate Stock Price Change Rate ＜2861＞ Top French Bonds 10 107185.08 400% 0% ＜5952＞ Amate
Is there a strong buying advantage due to strong and strong US stock support
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to develop steadily. On the US stock market yesterday 27th, the Dow Jones Industrial Average rose 477.75 dollars (+ 1.22%) to 39760.08 dollars, and rebounded drastically for the first time in 4 days. Purchases based on a sense of affordability, recovery in some high-tech stocks such as mobile terminals Apple (AAPL) and electric vehicle Tesla (TSLA), and purchases in response to interest rate cuts and soft landing expectations were dominant. Buying is likely to be dominant in today's emerging markets. yesterday
Analysis
Price Target
No Data
